Estrella Immunopharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 2.8%.

Top 16 shareholders own 73.09% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
69.9%	Eureka Therapeutics, Inc.	25,277,831	US$25.3m	0%	no data
0.82%	Cheng Liu	297,437	US$297.4k	0%	no data
0.73%	Jiandong Xu	264,388	US$264.4k	0%	no data
0.66%	Hong Zhang	240,481	US$240.5k	0%	no data
0.4%	Victor Shum	144,443	US$144.4k	0%	no data
0.21%	Geode Capital Management, LLC	76,556	US$76.6k	31.5%	no data
0.11%	ATW SPAC Management LLC	40,000	US$40.0k	0%	0.04%
0.08%	Vivien Chan	28,889	US$28.9k	0%	no data
0.069%	BlackRock, Inc.	24,963	US$25.0k	230%	no data
0.06%	The Vanguard Group, Inc.	21,684	US$21.7k	484%	no data
0.04%	Citadel Advisors LLC	14,531	US$14.5k	0%	no data
0.028%	Maso Capital Partners Ltd	10,000	US$10.0k	0%	0.01%
0.018%	UBS Asset Management AG	6,523	US$6.5k	0%	no data
0.016%	Tower Research Capital Europe Limited	5,728	US$5.7k	-19.9%	no data
0.00023%	Bank of America Corporation, Asset Management Arm	83	US$83.2	6.41%	no data
0.00007%	JPMorgan Chase & Co, Brokerage and Securities Investments	27	US$25.3	3.85%	no data